EichorEICHOR
Study identifier: NCT07003919 Synced from ClinicalTrials.gov · August 02, 2026
● Active Not Recruiting

Safety Study of Viaskin® Peanut Patch in Peanut-Allergic Children 1 Through 3 Years of Age (COMFORT Toddlers)

Condition: Allergy · Peanut Allergy  ·  Sponsor: DBV Technologies

PhasePhase 3
Planned participants480
Who can joinAll sexes, 1 Year to 3 Years
Healthy volunteersNo

About this study

The primary objective of this study is to assess the 6-month safety of DBV712 250 micrograms (mcg) in subjects 1 through 3 years of age with peanut allergy.

This description comes directly from the study's public registry record.

Talk to the study team

No contact information is available for this study as per the public registry record.

Always discuss trial participation with your own doctor first.

Locations (91)

AllerVie Clinical ResearchBirmingham, Alabama, United States
University of Alabama at Birmingham Pediatric Primary Care ClinicBirmingham, Alabama, United States
Modena Allergy & AsthmaScottsdale, Arizona, United States
University of Arizona Asthma and Airway Disease Research CenterTucson, Arizona, United States
Arkansas Children's HospitalLittle Rock, Arkansas, United States
Modena Allergy & AsthmaLa Jolla, California, United States
Modena Allergy and AsthmaLong Beach, California, United States
UCLA Health Westwood PediatricsLos Angeles, California, United States
Children's Hospital of Los AngelesLos Angeles, California, United States
Allergy & Asthma Associates of Southern CaliforniaMission Viejo, California, United States
Lucile Packard Children's Hospital StanfordPalo Alto, California, United States
Allergy & Asthma Medical Group and Research CenterSan Diego, California, United States

+ 79 more locations — full list on the registry record.

Follow this study

Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.

We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →